Suppr超能文献

鉴定一个与LRRK2基因p.R1441G相关帕金森病的日裔家族。

Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.

作者信息

Hatano Taku, Funayama Manabu, Kubo Shin-Ichiro, Mata Ignacio F, Oji Yutaka, Mori Akio, Zabetian Cyrus P, Waldherr Sarah M, Yoshino Hiroyo, Oyama Genko, Shimo Yasushi, Fujimoto Ken-Ichi, Oshima Hirokazu, Kunii Yasuto, Yabe Hirooki, Mizuno Yoshikuni, Hattori Nobutaka

机构信息

Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.

Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan; Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, Japan.

出版信息

Neurobiol Aging. 2014 Nov;35(11):2656.e17-2656.e23. doi: 10.1016/j.neurobiolaging.2014.05.025. Epub 2014 Jun 2.

Abstract

Leucine-rich repeat kinase 2 (LRRK2) is a causative gene of autosomal dominant familial Parkinson's disease (PD). We screened for LRRK2 mutations in 3 frequently reported exons (31, 41, and 48) in our cohort of 871 Japanese patients with PD (430 with sporadic PD and 441 probands with familial PD). Direct sequencing analysis of LRRK2 revealed 1 proband (0.11%) with a p.R1441G mutation, identified for the first time in Asian countries, besides frequently reported substitutions including, the p.G2019S mutation (0.11%) and p.G2385R variant (11.37%). Several studies have suggested that the LRRK2 p.R1441G mutation, which is highly prevalent in the Basque country, is extremely rare outside of northern Spain. Further analysis of family members of the proband with the p.R1441G mutation revealed that her mother and first cousin shared the same mutation and parkinsonism. Haplotype analysis revealed a different haplotype from that of the original Spanish families. Our patients demonstrated levodopa-responsive parkinsonism with intrafamilial clinical heterogeneity. This is the first report of familial PD because of the LRRK2 p.R1441G mutation in Asia.

摘要

富含亮氨酸重复激酶2(LRRK2)是常染色体显性遗传性帕金森病(PD)的致病基因。我们在871名日本PD患者(430例散发性PD患者和441例家族性PD先证者)队列中,对3个频繁报道的外显子(31、41和48)进行了LRRK2突变筛查。LRRK2的直接测序分析显示,有1名先证者(0.11%)存在p.R1441G突变,这是亚洲国家首次发现,此外还有一些常见的替代突变,包括p.G2019S突变(0.11%)和p.G2385R变异(11.37%)。多项研究表明,LRRK2 p.R1441G突变在巴斯克地区非常普遍,在西班牙北部以外地区极为罕见。对携带p.R1441G突变的先证者家庭成员的进一步分析显示,她的母亲和一级表亲都有相同的突变和帕金森症。单倍型分析显示,其单倍型与最初的西班牙家族不同。我们的患者表现出左旋多巴反应性帕金森症,且家族内存在临床异质性。这是亚洲地区关于LRRK2 p.R1441G突变导致家族性PD的首次报道。

相似文献

1
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.鉴定一个与LRRK2基因p.R1441G相关帕金森病的日裔家族。
Neurobiol Aging. 2014 Nov;35(11):2656.e17-2656.e23. doi: 10.1016/j.neurobiolaging.2014.05.025. Epub 2014 Jun 2.
3
LRRK2 R1441G in Spanish patients with Parkinson's disease.西班牙帕金森病患者中的LRRK2 R1441G
Neurosci Lett. 2005 Jul 15;382(3):309-11. doi: 10.1016/j.neulet.2005.03.033. Epub 2005 Apr 13.
8

引用本文的文献

3
Pain in monogenic Parkinson's disease: a comprehensive review.单基因帕金森病中的疼痛:一项综合综述。
Front Neurol. 2023 Oct 30;14:1248828. doi: 10.3389/fneur.2023.1248828. eCollection 2023.

本文引用的文献

1
Autonomic dysfunction in parkinsonian LRRK2 mutation carriers.帕金森病 LRRK2 突变携带者的自主神经功能障碍。
Parkinsonism Relat Disord. 2013 Oct;19(10):906-9. doi: 10.1016/j.parkreldis.2013.05.008. Epub 2013 Jun 10.
2
The spectrum of nonmotor symptoms in early Parkinson disease.早期帕金森病的非运动症状谱。
Neurology. 2013 Jan 15;80(3):276-81. doi: 10.1212/WNL.0b013e31827deb74.
3
LRRK2 I2020T mutation is associated with tau pathology.LRRK2 I2020T 突变与 tau 病理学有关。
Parkinsonism Relat Disord. 2012 Aug;18(7):819-23. doi: 10.1016/j.parkreldis.2012.03.024. Epub 2012 Apr 22.
7
Clinical features of LRRK2 parkinsonism.LRRK2 帕金森病的临床特征。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S205-8. doi: 10.1016/S1353-8020(09)70815-6.
10
LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay.来自秘鲁和乌拉圭的帕金森病患者的LRRK2突变
Parkinsonism Relat Disord. 2009 Jun;15(5):370-3. doi: 10.1016/j.parkreldis.2008.09.002. Epub 2008 Nov 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验